In the study conducted by Yin et al., it has been demonstrated that hnRNPA2B1 plays a role in the upregulation and modulation of cell division protein kinase 6 (CDK6) expression in NSCLC cell lines. Here, HNRNPA2B1 is linked to non-small cell lung carcinoma.